From BioHealth Investor
by H.S. Ayoub
BioHealth Investor
Stem cell stocks gained big time on Thursday as the new U.S. congress was set to take helm. The new Domocratic agenda promises to ease restrictions on embryonic stem cell research funding imposed by the Bush administration.
While Bush is expected to veto the new legislation, critics believe there is enough push in the Senate to over-ride the veto.
It is exptected that under a Democratic environment biotech stocks in general should perform well over the next few years, especially contraversial areas such as embryonic stem cell research.
Shares of Geron (GERN), StemCells (STEM), Aastrom (ASTM), Thermogenesis (KOOL), LifeCell (LIFC), Advanced Cell Technology (ACTC), Viacell (VIAC). Cryo-Cell (CCEL), and Cord Bloog America (CBAI) all gained on the day.
Aastrom, StemCells, Cord Blood America and Advanced Cell Technology all gained by double digit percentage points.
http://www.biohealthinvestor.com/
Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
